歐盟5國的MA (醫療事務) 部門的評估:氣喘/COPD
Medical Affairs Reputations: Asthma/COPD (EU5) 2017
|歐盟5國的MA (醫療事務) 部門的評估:氣喘/COPD Medical Affairs Reputations: Asthma/COPD (EU5) 2017|
|出版日期: 2017年09月01日||內容資訊: 英文||
本報告提供處理氣喘/COPD的治療藥主要12項產品的各公司醫療事務 (MA)團隊相關歐盟5國 (法國、義大利、德國、西班牙、英國)的150名呼吸系統科醫生及一般醫生的調查 ，對各公司團隊的效能及滿意度的評分及排行榜，醫生的服務利用趨勢，要求，改善地方分析等彙整資料。
How well does your asthma/COPD medical affairs team performance compare with the rest?
According to this latest survey of 150 pulmonologists and primary care physicians across the EU5 (UK, France, Germany, Italy and Spain) the performance of asthma/COPD medical affairs teams still has a way to go in some key areas. Find out what physicians think is done well; what they want to see more of; and why some are dissatisfied.
Use Medical Affairs Reputations: Asthma/COPD 2017 (EU5) to discover how your team can better meet the high expectations of physicians at the frontline.
This report compares the current activities of medical affairs teams for the 12 leading treatments for asthma/COPD from AstraZeneca, Boehringer Ingelheim, GSK, and Novartis. It shows:
It's time to find out exactly how well your medical affairs team is performing against fierce competition - and establish an action plan to gain competitive advantage.
Interested in the US market? Click here to see the US Edition.
Request sample pages
Insight into Medical affairs teams for these asthma/COPD treatments
A Competitive View of Your Medical Affairs Team
Developed with the help of medical affairs specialists, this report gives you an in-depth comparison of medical affairs teams for 12 leading asthma/COPD brands-answering important questions like:
What do physicians need?
Does your medical affairs team deliver?
What needs improvement?
Based on Interviews with Practicing Doctors
We surveyed 150 pulmonologists and primary care physicians from the EU5 (France, Italy, Germany, Spain, UK) chosen from the largest community of validated physicians in the world
We conducted the survey between September 1-14, 2017.
Money Back Guarantee!
At FirstWord, we stand behind our reports. If you're not completely satisfied, we'll refund your money. Guaranteed.
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company's success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.
Learn more at www.firstwordgroup.com.